Rigel Pharmaceuticals
RIGL
RIGL
149 hedge funds and large institutions have $489M invested in Rigel Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 42 increasing their positions, 51 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0.01% more ownership
Funds ownership: 8.27% → 8.28% (+0.01%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
18% less repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 51
Holders
149
Holding in Top 10
1
Calls
$2.51M
Puts
$2.15M
Top Buyers
| 1 | +$8.15M | |
| 2 | +$6.9M | |
| 3 | +$6.41M | |
| 4 |
Norges Bank
Oslo,
Norway
|
+$2.02M |
| 5 |
JP Morgan Chase
New York
|
+$1.81M |
Top Sellers
| 1 | -$8.82M | |
| 2 | -$4.52M | |
| 3 | -$3.63M | |
| 4 |
State Street
Boston,
Massachusetts
|
-$2.6M |
| 5 |
JGC
J. Goldman & Co
New York
|
-$2.6M |